Skip to content
10-K

Annual Report

BIOATLA, INC. BCAB

0001193125-26-134499

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 58.83M sh
Shares Diluted FY 2025 · Dec 31, 2024 48.57M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$48.2M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$71.94M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.12M
Cash And Equivalents FY 2025 · Dec 31, 2024 $49.05M
Stockholders Equity FY 2025 · Dec 31, 2025 −$36.19M
Stockholders Equity FY 2025 · Dec 31, 2024 $14.27M
Current Liabilities FY 2025 · Dec 31, 2025 $21.92M
Current Liabilities FY 2025 · Dec 31, 2024 $14.54M
Total Liabilities FY 2025 · Dec 31, 2025 $50.02M
Total Liabilities FY 2025 · Dec 31, 2024 $38.16M
Current Assets FY 2025 · Dec 31, 2025 $8.01M
Current Assets FY 2025 · Dec 31, 2024 $51.23M
Total Assets FY 2025 · Dec 31, 2025 $13.83M
Total Assets FY 2025 · Dec 31, 2024 $52.42M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.01
Eps Diluted FY 2025 · Dec 31, 2024 −$1.44
Eps Basic FY 2025 · Dec 31, 2025 −$1.01
Eps Basic FY 2025 · Dec 31, 2024 −$1.44
Sga Expense FY 2025 · Dec 31, 2025 $17.73M
Sga Expense FY 2025 · Dec 31, 2024 $21.85M
Rd Expense FY 2025 · Dec 31, 2025 $43.57M
Rd Expense FY 2025 · Dec 31, 2024 $63.1M
Net Income FY 2025 · Dec 31, 2025 −$59.61M
Net Income FY 2025 · Dec 31, 2024 −$69.78M
Operating Income FY 2025 · Dec 31, 2025 −$59.31M
Operating Income FY 2025 · Dec 31, 2024 −$73.94M